HomeHealthCIRM Awards Acurastem $7.5 Million In Grant Funding To Advance AS-241 Toward...

CIRM Awards Acurastem $7.5 Million In Grant Funding To Advance AS-241 Toward A First-In-Human Trial For ALS And FTD

April 28, 2026

(MENAFN – PR Newswire) PASADENA, Calif. , April 28, 2026 /PRNewswire/ — AcuraStem, a biotechnology company advancing treatments for amyotrophic lateral sclerosis (ALS), frontotemporal dementia. ..

Read full story on Menafn

Futurhealth Among The First To Offer Eli Lilly’s Oral GLP-1, Orforglipron, Expanding Access To Next-Generation, Non-Injectable Treatment

Oil prices rise 3% as Iran war stand-off persists

CIRM Awards Acurastem $7.5 Million In Grant Funding To Advance AS-241 Toward A First-In-Human Trial For ALS And FTD

Man, 40, survived in China hospital even after heart stopped beating for more than 40 hours

Water Treatment Expert Jason Mcgee Of Loretto Explains How Local Suppliers Improve Safety And Reliability For Hellonation

ملک میں ایچ آئی وی کے پھیلاؤ نے خطرے کی گھنٹی بجا دی

LEAVE A REPLY Cancel reply

Most Popular

بندر پکڑو ۔۔۔ انعام پاؤ، بھارت میں حکومت کا انوکھا طریقہ

Man, 40, survived in China hospital even after heart stopped beating for more than 40 hours

ہانیہ عامر، عاصم اظہر کے نام کا ماسک پہن کر کنسرٹ میں پہنچ گئیں

Water Treatment Expert Jason Mcgee Of Loretto Explains How Local Suppliers Improve Safety And Reliability For Hellonation

Recent Comments